STOCK TITAN

[Form 4] INTUITIVE SURGICAL INC Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Gary Loeb, EVP & Chief Legal and Compliance at Intuitive Surgical (ISRG), reported beneficial ownership changes on 10/10/2025. A vesting event converted 2,612 restricted stock units into common shares (transaction code M), with net shares deposited after withholding for taxes. Immediately following the vesting, the filing shows a sale/disposition of 1,296 shares at $443.76 (transaction code F), leaving the reporting person with 3,561 shares beneficially owned. The RSU grant vests 25% annually over four years, and the filing notes that 25% of the grant was released at this vesting date.

Gary Loeb, EVP e Responsabile Legale e Compliance presso Intuitive Surgical (ISRG), ha riferito cambiamenti nella proprietà beneficiaria in data 10/10/2025. Un evento di vesting ha convertito 2.612 restricted stock units in azioni ordinarie ( codice di transazione M ), con azioni nette depositate dopo la trattenuta per le tasse. Subito dopo il vesting, la dichiarazione mostra una vendita/disposizione di 1.296 azioni a $443,76 (codice di transazione F), lasciando l'individuo che riporta possessi benefici a 3.561 azioni. Il grant RSU veste 25% annualmente in quattro anni, e la dichiarazione nota che il 25% del grant è stato rilasciato in questa data di vesting.

Gary Loeb, EVP y Director Jurídico y de Cumplimiento en Intuitive Surgical (ISRG), informó cambios en la propiedad beneficiosa en la fecha 10/10/2025. Un evento de vesting convirtió 2,612 unidades de acciones restringidas en acciones ordinarias (código de transacción M), con acciones netas depositadas después de la retención de impuestos. Justo después del vesting, el filing muestra una venta/disposición de 1,296 acciones a $443.76 (código de transacción F), dejando a la persona que reporta con 3,561 acciones beneficiosas. El otorgamiento RSU vence 25% anualmente durante cuatro años, y la declaración señala que el 25% del otorgamiento fue liberado en esta fecha de vesting.

Gary Loeb는 ISRG로 알려진 Intuitive Surgical의 EVP 겸 법률 및 컴플라이언스 최고책임자로, 보고서에 따라 10/10/2025에 유익한 소유권 변경이 있었습니다. vesting 이벤트로 2,612장의 제한 주식 단위가 보통주로 전환되었고(거래 코드 M), 세금 원천징수 후 순 주식이 예치되었습니다. 즉시 vesting 직후, 신고서는 1,296주를 $443.76에 매각/처분했다고 표시하며(거래 코드 F), 보고인에게는 3,561주의 이익 소유 주식이 남습니다. RSU 부여는 4년간 매년 25%씩 vesting되며, 신고서는 이번 vesting 날짜에 25%가 해제되었다고 명시합니다.

Gary Loeb, VP exécutif et Directeur juridique et conformité chez Intuitive Surgical (ISRG), a signalé des changements de propriété bénéficiaire à la date 10/10/2025. Un événement d'acquisition vesting a converti 2 612 unités d'actions restreintes en actions ordinaires (code de transaction M), avec les actions nettes déposées après retenue d'impôt. Immédiatement après le vesting, le dossier indique une vente/Disposition de 1 296 actions à $443.76 (code de transaction F), laissant la personne déclarante détenir 3 561 actions bénéficiaires. La subvention RSU se libère à 25% annuellement sur quatre ans, et le dossier note que 25% de la subvention a été libéré à cette date de vesting.

Gary Loeb, EVP und Chief Legal and Compliance bei Intuitive Surgical (ISRG), meldete Änderungen der wirtschaftlich Berechtigten am 10/10/2025. Ein Vesting-Ereignis verwandelte 2.612 Restricted Stock Units in Stammaktien (Transaktionscode M), wobei Nettobestände nach Steuern einbehalten wurden. Unmittelbar nach dem Vesting zeigt die Meldung einen Verkauf/Veräußerung von 1.296 Aktien zu $443,76 (Transaktionscode F), wodurch die meldende Person 3.561 Aktien wirtschaftlich berechtigt hält. Die RSU-Zuweisung vestet 25% jährlich über vier Jahre, und im Bericht wird vermerkt, dass 25% des Grantees zu diesem Vesting-Datum freigegeben wurden.

Gary Loeb، نائب الرئيس التنفيذي والمدير القانوني والامتثال لدى Intuitive Surgical (ISRG)، أبلغ عن تغيّرات في الملكية المستفيدة بتاريخ 10/10/2025. حدث vesting حوّل 2,612 وحدة أسهم مقيدة إلى أسهم عادية (رمز المعاملة M)، مع إيداع الأسهم الصافية بعد اقتطاع الضرائب. مباشرة بعد vesting، يظهر الملف بيع/تصرف بـ 1,296 سهم بسعر $443.76 (رمز المعاملة F)، مما يترك الشخص المبلغ عنه يملك 3,561 سهمًا مستفيدًا. منح RSU يتقادم vesting 25% سنويًا على مدى أربع سنوات، وتذكر البيان أن 25% من المنحة تم الإفراج عنها في تاريخ vesting هذا.

Gary Loeb,ISVP 与首席法务与合规官,隶属于 Intuitive Surgical (ISRG),在 2025/10/10 报告了实益所有权变动。一项归属事件将 2,612 份受限股票单位转换为普通股(交易代码 M),税后净股数已存入。紧随归属之后,申报显示以 $443.76 价格出售/处置 1,296 股(交易代码 F),使报告人持有的受益所有权股数为 3,561 股。RSU 授予在四年内每年归属 25%,且申报指出在本次归属日期释放了 25% 的授予部分。

Positive
  • Continued ownership of 3,561 shares after transactions indicates retained equity exposure
  • RSU vesting follows the disclosed 25%-per-year schedule, reflecting predictable compensation mechanics
Negative
  • Partial sale of 1,296 shares at $443.76 reduced holdings and introduced short-term liquidity
  • Tax withholding required retention of some vested shares, reducing net deposited shares from the full vested amount

Insights

RSU vesting and a partial sale reflect routine compensation settlement and tax withholding.

The filing documents an automatic conversion of 2,612 restricted stock units into common stock on 10/10/2025, consistent with a standard 25%-per-year vesting schedule. A portion of the vested shares were withheld for statutory taxes and the remaining net shares were deposited to the holder's account.

The subsequent disposal of 1,296 shares at $443.76 appears as a separate sale reducing beneficial ownership to 3,561 shares. Monitor remaining vesting tranches (annual through the fourth anniversary) for future share inflows and potential sales within the next 12 months.

Insider retained a majority of vested shares, indicating partial liquidity rather than full exit.

The reporting person retained net shares after tax withholding and sold roughly 49.6% of the vested shares (1,296 of 2,612). Ownership after the transactions remained at 3,561 shares, showing continued equity exposure.

Key items to watch include scheduled vesting on remaining RSU installments and any future Form 4 entries that would show additional sales or purchases across the next 12–36 months.

Gary Loeb, EVP e Responsabile Legale e Compliance presso Intuitive Surgical (ISRG), ha riferito cambiamenti nella proprietà beneficiaria in data 10/10/2025. Un evento di vesting ha convertito 2.612 restricted stock units in azioni ordinarie ( codice di transazione M ), con azioni nette depositate dopo la trattenuta per le tasse. Subito dopo il vesting, la dichiarazione mostra una vendita/disposizione di 1.296 azioni a $443,76 (codice di transazione F), lasciando l'individuo che riporta possessi benefici a 3.561 azioni. Il grant RSU veste 25% annualmente in quattro anni, e la dichiarazione nota che il 25% del grant è stato rilasciato in questa data di vesting.

Gary Loeb, EVP y Director Jurídico y de Cumplimiento en Intuitive Surgical (ISRG), informó cambios en la propiedad beneficiosa en la fecha 10/10/2025. Un evento de vesting convirtió 2,612 unidades de acciones restringidas en acciones ordinarias (código de transacción M), con acciones netas depositadas después de la retención de impuestos. Justo después del vesting, el filing muestra una venta/disposición de 1,296 acciones a $443.76 (código de transacción F), dejando a la persona que reporta con 3,561 acciones beneficiosas. El otorgamiento RSU vence 25% anualmente durante cuatro años, y la declaración señala que el 25% del otorgamiento fue liberado en esta fecha de vesting.

Gary Loeb는 ISRG로 알려진 Intuitive Surgical의 EVP 겸 법률 및 컴플라이언스 최고책임자로, 보고서에 따라 10/10/2025에 유익한 소유권 변경이 있었습니다. vesting 이벤트로 2,612장의 제한 주식 단위가 보통주로 전환되었고(거래 코드 M), 세금 원천징수 후 순 주식이 예치되었습니다. 즉시 vesting 직후, 신고서는 1,296주를 $443.76에 매각/처분했다고 표시하며(거래 코드 F), 보고인에게는 3,561주의 이익 소유 주식이 남습니다. RSU 부여는 4년간 매년 25%씩 vesting되며, 신고서는 이번 vesting 날짜에 25%가 해제되었다고 명시합니다.

Gary Loeb, VP exécutif et Directeur juridique et conformité chez Intuitive Surgical (ISRG), a signalé des changements de propriété bénéficiaire à la date 10/10/2025. Un événement d'acquisition vesting a converti 2 612 unités d'actions restreintes en actions ordinaires (code de transaction M), avec les actions nettes déposées après retenue d'impôt. Immédiatement après le vesting, le dossier indique une vente/Disposition de 1 296 actions à $443.76 (code de transaction F), laissant la personne déclarante détenir 3 561 actions bénéficiaires. La subvention RSU se libère à 25% annuellement sur quatre ans, et le dossier note que 25% de la subvention a été libéré à cette date de vesting.

Gary Loeb, EVP und Chief Legal and Compliance bei Intuitive Surgical (ISRG), meldete Änderungen der wirtschaftlich Berechtigten am 10/10/2025. Ein Vesting-Ereignis verwandelte 2.612 Restricted Stock Units in Stammaktien (Transaktionscode M), wobei Nettobestände nach Steuern einbehalten wurden. Unmittelbar nach dem Vesting zeigt die Meldung einen Verkauf/Veräußerung von 1.296 Aktien zu $443,76 (Transaktionscode F), wodurch die meldende Person 3.561 Aktien wirtschaftlich berechtigt hält. Die RSU-Zuweisung vestet 25% jährlich über vier Jahre, und im Bericht wird vermerkt, dass 25% des Grantees zu diesem Vesting-Datum freigegeben wurden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LOEB GARY

(Last) (First) (Middle)
1020 KIFER ROAD

(Street)
SUNNYVALE CA 94086

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Chief Legal and Complian
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/10/2025 M(1) 2,612 A $0.0 4,857 D
Common Stock 10/10/2025 F(1) 1,296 D $443.76 3,561 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0.0 10/10/2025 M 2,612 (2) 10/10/2026 Common Stock 0 $0.0 2,612 D
Explanation of Responses:
1. RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
2. Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.
By: Stephanie Lim-Ignacio For: Loeb, Gary Howard 10/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ISRG insider Gary Loeb report on the Form 4 filed 10/10/2025?

The filing reports vesting of 2,612 RSUs converted to common stock and a sale of 1,296 shares at $443.76, leaving 3,561 shares beneficially owned.

How do the vested RSUs for Gary Loeb vest?

Each RSU grant vests 25% per year over a four-year period, with a one-for-one conversion to common stock on each vest date.

How many shares were withheld for taxes at vesting?

The filing states a portion of the released 2,612 shares were held back for statutory tax withholding; the exact withheld count is not specified.

What was the net effect on beneficial ownership after the transactions?

Beneficial ownership decreased to 3,561 shares following the vesting and the sale.

Was the sale tied to a trading plan (Rule 10b5-1)?

The filing includes the standard plan checkbox language but does not indicate that this specific sale was executed under a Rule 10b5-1 plan.
Intuitive Surgical Inc

NASDAQ:ISRG

ISRG Rankings

ISRG Latest News

ISRG Latest SEC Filings

ISRG Stock Data

159.08B
356.22M
0.53%
89.01%
1.52%
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
SUNNYVALE